A detailed history of Roberts Glore & CO Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Roberts Glore & CO Inc holds 8,384 shares of BDX stock, worth $1.91 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
8,384
Previous 8,389 0.06%
Holding current value
$1.91 Million
Previous $1.96 Million 3.11%
% of portfolio
0.59%
Previous 0.6%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$221.47 - $242.41 $1,107 - $1,212
-5 Reduced 0.06%
8,384 $2.02 Million
Q2 2024

Aug 14, 2024

BUY
$225.07 - $246.17 $11,253 - $12,308
50 Added 0.6%
8,389 $1.96 Million
Q1 2024

May 09, 2024

SELL
$233.45 - $247.73 $59,062 - $62,675
-253 Reduced 2.94%
8,339 $2.06 Million
Q2 2023

Aug 14, 2023

SELL
$238.39 - $265.32 $8,343 - $9,286
-35 Reduced 0.41%
8,592 $2.27 Million
Q1 2023

May 08, 2023

SELL
$229.71 - $259.35 $26,646 - $30,084
-116 Reduced 1.33%
8,627 $2.14 Million
Q4 2022

Feb 13, 2023

BUY
$218.29 - $256.91 $141,888 - $166,991
650 Added 8.03%
8,743 $2.22 Million
Q3 2022

Nov 07, 2022

BUY
$51.03 - $264.23 $7,450 - $38,577
146 Added 1.84%
8,093 $1.8 Million
Q2 2022

Aug 11, 2022

BUY
$234.74 - $275.42 $32,394 - $38,007
138 Added 1.77%
7,947 $1.96 Million
Q1 2022

May 02, 2022

SELL
$243.64 - $270.48 $48,484 - $53,825
-199 Reduced 2.49%
7,809 $2.08 Million
Q3 2021

Nov 12, 2021

BUY
$232.72 - $256.47 $13,497 - $14,875
58 Added 0.73%
8,008 $1.97 Million
Q2 2021

Aug 10, 2021

SELL
$232.65 - $254.58 $10,003 - $10,946
-43 Reduced 0.54%
7,950 $1.93 Million
Q1 2021

May 06, 2021

BUY
$232.09 - $256.88 $5,802 - $6,422
25 Added 0.31%
7,993 $1.94 Million
Q4 2020

Feb 09, 2021

BUY
$221.92 - $245.94 $19,528 - $21,642
88 Added 1.12%
7,968 $1.99 Million
Q3 2020

Nov 06, 2020

BUY
$215.77 - $276.76 $138,740 - $177,956
643 Added 8.88%
7,880 $1.83 Million
Q2 2020

Aug 13, 2020

BUY
$219.9 - $263.41 $16,932 - $20,282
77 Added 1.08%
7,237 $1.73 Million
Q1 2020

May 11, 2020

BUY
$195.69 - $279.01 $32,288 - $46,036
165 Added 2.36%
7,160 $1.65 Million
Q4 2019

Feb 13, 2020

BUY
$236.45 - $266.82 $305,256 - $344,464
1,291 Added 22.63%
6,995 $1.9 Million
Q3 2019

Nov 08, 2019

SELL
$230.58 - $256.08 $23,058 - $25,608
-100 Reduced 1.72%
5,704 $1.44 Million
Q4 2018

Feb 08, 2019

SELL
$204.73 - $257.93 $35,827 - $45,137
-175 Reduced 2.93%
5,804 $1.31 Million
Q3 2018

Nov 09, 2018

SELL
$233.07 - $256.0 $11,653 - $12,800
-50 Reduced 0.83%
5,979 $1.56 Million
Q1 2018

May 08, 2018

BUY
$205.46 - $240.27 $24,655 - $28,832
120 Added 2.03%
6,029 $1.31 Million
Q4 2017

Feb 09, 2018

BUY
$189.0 - $222.64 $88,263 - $103,972
467 Added 8.58%
5,909 $1.27 Million
Q3 2017

Nov 08, 2017

SELL
$186.89 - $198.9 $193,431 - $205,861
-1,035 Reduced 15.98%
5,442 $1.07 Million
Q2 2017

Aug 15, 2017

BUY
N/A
6,477
6,477 $1.26 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Roberts Glore & CO Inc Portfolio

Follow Roberts Glore & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.